Cargando…
Effect of intravitreal dexamethasone solution on the reduction of macular thickness in pseudophakic diabetic patients in a public hospital in Brazil: a randomized clinical trial
PURPOSE: To determine the effect of short-term 4 mg/mL dexamethasone solution treatment in diabetic macular edema (DME). PATIENTS AND METHODS: Twenty-seven pseudophakic diabetic patients with visual impairment caused by DME were randomized to receive 0.01 mL (40 μg), 0.03 mL (120 μg) or 0.05 mL (200...
Autores principales: | Fonseca, Andre Luis A, Panetta, Heitor, Nascimento, Mauricio A, Lira, Rodrigo Pessoa C, Arieta, Carlos Eduardo L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693423/ https://www.ncbi.nlm.nih.gov/pubmed/31496644 http://dx.doi.org/10.2147/OPTH.S214329 |
Ejemplares similares
-
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019) -
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
por: Obis, Javier, et al.
Publicado: (2021) -
Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
por: Kakkassery, Vinodh, et al.
Publicado: (2017) -
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
por: Rodrigues, Magna Vanessa, et al.
Publicado: (2023) -
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
por: Dang, Yalong, et al.
Publicado: (2014)